Published online Feb 26, 2021. doi: 10.12998/wjcc.v9.i6.1483
Peer-review started: November 14, 2020
First decision: December 3, 2020
Revised: December 16, 2020
Accepted: December 27, 2020
Article in press: December 27, 2020
Published online: February 26, 2021
Processing time: 84 Days and 5.1 Hours
Gastrointestinal (GI) hemangioma has a low incidence among systemic hemangiomas, and some GI hemangiomas occur in the intestine, stomach, and esophagus. Polidocanol has been increasingly used in sclerotherapy. However, this paper reports that minimally invasive treatment of multiple hemangiomas with large diameters can achieve satisfactory results by multipoint injection.
A 46-year-old female patient was hospitalized in another hospital for cough. We accidentally found thickening of the lower esophagus by chest computed tomography. The patient was eventually diagnosed with multiple GI hemangiomas and underwent a series of examinations including esophagogastroduodenoscopy (EGD), endoscopic ultrasound, and magnetic resonance imaging. We calculated the dose of polidocanol according to the volumes of the hemangiomas, fixed the target vein with the help of a transparent cap, and then administered polidocanol via multipoint injection into the hemangiomas under endoscopic guidance. EGD and endoscopic ultrasound showed that the hemangiomas disappeared. The color of the esophageal mucosa returned to normal 1 mo after sclerotherapy.
Sclerotherapy may be a safe and effective method for treating multiple hemangiomas of the alimentary canal.
Core Tip: Multiple gastrointestinal (GI) hemangiomas are rare in clinical practice, and the current treatment method for lager GI hemangiomas is surgery. In this case, multipoint injection of polidocanol was used to treat gastroesophageal hemangiomas. We used a reasonable dose of polidocanol and applied the treatment using a transparent cap. This sclerotherapy method successfully treated a patient with multiple hemangiomas without any complications.